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To The Editor: we read with interest the good 
review article by Drs Sterner and Nyman [1] 
concerning the safe use of intravascular contrast 
medium for both coronary interventions and multi-
channel detector computed tomography.  
As a radiology department in the United 
Kingdom, our current policy is to follow specific 
guidelines issued by the Royal College of 
Radiologists [2] 
When compared, the two publications hold many 
similarities with respect to their recommendations 
for clinical practice. This is especially true with the 
recommendations for optimising the patient’s renal 
state prior to any procedure requiring the 
administration of intravascular contrast media. 
However, on a practical note, we would suggest 
that the different calculations proposed to 
determine the Glomerular Filtration Rate [3-5] are 
too complex for use in every patient requiring 
intravascular contrast medium. As a department, 
we continue to use baseline creatinine levels as a 
screening tool in high risk patients (i.e. the elderly 
and patients with a history of diabetes and/or renal 
disease). We have found this to be sufficient.  
A review paper by P. Aspelin [6] conveys a very 
similar message but perhaps in a more general 
physician-orientated approach. His concluding 
recommendations are simple: confirm the need for 
contrast media, identify the at risk patient, hydrate 
adequately, discontinue nephrotoxic drugs before 
the procedure, and choose a contrast medium with 
the lowest nephrotoxic effects. These simple 
guidelines are perhaps more appropriate for day-
to-day practice and for general distribution to 
referring clinicians who may be deterred by the 
more complicated equations in the other 
publications. 
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We thank Drs. Rayner and Abdulkarim for their 
interest and appreciating comments on our article 
[1], and the editors of Libyan J Med for the 
opportunity to respond to their Letter. Drs. Rayner 
and Abdulkarim found our recommendation to use 
estimated glomerular filtration rate (eGFR) rather 
than serum creatinine alone too complex “in every 
patient requiring intravascular contrast medium” 
and prefer a “more general physician-oriented 
approach”.  
Firstly, according to our presented guidelines we 
only recommend serum creatinine to calculate 
GFR in “patients with suspected or known renal 
disease/-surgery/-impairment, diabetes mellitus, 
congestive heart failure, age >70 years or in any 
other obvious risk factor” [1]. 
Secondly, it is well recognised that serum 
creatinine is a poor predictor of GFR (the best 
overall measure of renal function), to a large 
extent due to its dependent on muscular mass. 
Therefore the National Kidney Foundation (NKF; 
USA) [2] as well as the American Heart 
Association (AHA) Science Advisory Board 2006 
[3] have strongly recommended that “serum 
creatinine concentration alone should not be used 
to assess the level of kidney function”. They 
further state that “the level of GFR should be 
estimated from prediction equations that take into 
account the serum creatinine concentration and 
some or all of the following: age, gender, race, 
and body size. In adults, the MDRD Study and 
Cockcroft-Gault equations provide useful 
estimates of GFR”. As an example a 50-year old 
80-kg male with a serum creatinine of 100 mmol/L 
will have an essentially normal eGFR of 89 
mL/min according to the Cockcroft-Gault formula, 
while it will be calculated to only 30 mL/min 
(borderline to severe kidney according to NKF) at 
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the same serum creatinine level in an 80-year old 
50-kg female. Thus, ignoring muscle mass and 
simply relying of serum creatinine may result in a 
substantial overestimation of GFR, especially in 
elderly low-weight patients. 
Thirdly, using eGFR to form a ratio between the 
planned contrast medium dose and eGFR has 
recently been advocated for improved risk 
assessment [4,5,6,7]. 
Fourthly and finally, regarding the complexity to 
do the GFR calculations there are numbers of 
calculators freely available on the internet for 
download;e.g. 
kidney.org/professionals/KDOQI/gfr_calculator.cfm. It 
just takes a few seconds to fill it in.  
Considering the potential consequences of a 
severe contrast-induced nephropathy, we believe 
that we owe the patient the effort to overcome this 
complexity.  
In conclusion, our message is that health care 
should take a patient-oriented rather than a 
comfortable  physician-oriented approach. 
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